Volume 24, Issue 103, May - June, 2020

Effusion associated comorbidities in a group of Saudi Patients

Hussain Gadelkarim Ahmed^1,2,3, Kheder Mohamed Altayep⁴, Emad Abboh Abdallah Abboh¹, Nuha Abdel Rahman Khalil¹, Amany Mohammed Khalifa¹, Amel Bakri Mohammed El Hag¹, Mohd Saleem¹, Soha Abdallah Moursi¹, Ruba Mustafa Elsaid¹, Mohammed Ahmed Babikir Bealy¹, Jabar Aziz Z. Alshamri¹, Abdallah Moursi¹, Kamaleldin B Said¹, Ghorashy Eltayeb Yousif Mohammed¹, Khalid Farhan Alshammari¹, Malik Asif Hussain¹

¹Department of Pathology, College of Medicine, University of Hail, Saudi Arabia
²Molecular Diagnostics and Personalized Therapeutics Unit, University of Ha’il, KSA
³Department of Histopathology and Cytology, FMLS, University of Khartoum, Sudan
⁴Department of Medicine, King Khalid Hospital, Hail, Saudi Arabia

ABSTRACT

Background: Effusion diagnosis usually presents a challenge to physicians, thus this study aimed to assess the effusion associated comorbidities in a group of Saudi Patients. Methodology: In this study, 62 patients presented with effusions were retrospectively investigated in King Khalid Hospital, Hail, Northern Saudi Arabia. The sample size representing one-year of a full coverage sample. Results: The highest proportion of patients were found with Hypertension (HNT) followed by Diabetes Mellitus (DM), Cancer, Ischemic Heart Disease (IHD), Chronic Kidney Disease (CKD), both Nephropathy& Hypothyroidism, both Hepatitis & Tuberculosis (TB), Liver Cirrhosis, constituting 40/62(64.5%), 37/62(60%), 19/62(30.6%), 11/62(17.7%), 6/62(9.7%), 4/62(6.5%), 3/62(4.8%) and 2/62(3.2%), respectively. Conclusion: Effusions etiology can be linked to the most common comorbid diseases including hypertension and type 2 diabetes mellitus, the highly prevalent comorbidities worldwide.

Keywords: Effusion, Exudate, transudate, hypertension, diabetes, cancer, comorbidities, Saudi Arabia

Medical Science, 2020, 24(103), 1343-1349

PDF